Paul Jan Bröckelmann

28PUBLICATIONS
109CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesGene and molecular therapyBiomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 21, 2026
BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.

|Jun 10, 2026
Brentuximab vedotin after alloSCT for relapsed/refractory Hodgkin lymphoma: GHSG BV-ALLO phase 2 trial.

|Apr 02, 2026
Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial.

Anne Sophie Robertz, Ina Bühnen, Julia Meissner

|Jan 27, 2026
Rapid molecular response kinetics to anti-PD-1-based first-line treatment of Hodgkin lymphoma in the GHSG NIVAHL trial.

Jan-Michel Heger, Julia Mattlener, Peter Herhaus

|Jan 26, 2026
Establishment and characterization of a CCND1-rearranged non-mantle cell lymphoma cell line and patient-derived xenograft model.

Claus-Moritz Gräf, Moritz Reese, Angela Vicente-Luque

|Dec 24, 2025
Four Months of Exercise Intervention Improved Visuomotor, Functional and Cardiorespiratory Capacity in a Patient with Metastatic Uveal Melanoma.

Michael Mendes Wefelnberg, Stefanie Hennigfeld, Michael Simon

Pageof 5

Frequent Collaborators

12 joint publications

Bastian von Tresckow

9 joint publications

Carsten Kobe

6 joint publications

Wolfram Klapper

5 joint publications

Dennis A Eichenauer